您当前的位置: 首页 > 数据库
  • 全部(2447)
  • 腹部手术(342)
  • 胸科手术(70)
  • 血管手术(5)
  • 心脏手术(97)
  • 神经外科(4)
  • 头颈部(35)
  • 骨科(78)
  • 泌尿外科(0)
  • 妇产手术(77)
  • 日间手术(26)
  • 手术室外(28)
  • 创伤和烧伤(0)
  • 非心脏手术(472)
  • 老年(0)
  • 小儿新生儿(189)
  • 特殊患者(42)
  • 未说明手术类型(982)
  • 术前宣教(21)
  • 术前评估(33)
  • 术前用药(15)
  • 术前禁食水(12)
  • 麻醉选择(21)
  • 麻醉用药(10)
  • 术中监测(23)
  • 液体管理(14)
  • 血液保护(3)
  • 体温管理(8)
  • 术后疼痛(62)
  • POD(8)
  • PONV(10)
  • 术后康复(50)
  • 特殊情况(43)
  • 术前肠道准备(9)
Array ( [id] => 3008 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3008.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 目标导向液体治疗有助于减少普通外科和心胸外科手术患者术后肺部并发症,联合正性肌力药物和 (或) 缩血管药物使用效果更明显(证据等级:中,推荐强度:强推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
目标导向液体治疗有助于减少普通外科和心胸外科手术患者术后肺部并发症,联合正性肌力药物和 (或) 缩血管药物使用效果更明显(证据等级:中,推荐强度:强推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3009 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3009.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 输注常规剂量羟乙基淀粉溶液对大手术后肾功能没有明显影响(证据等级:中,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
输注常规剂量羟乙基淀粉溶液对大手术后肾功能没有明显影响(证据等级:中,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3010 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3010.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => N‑末端 B 型利钠肽原 (NT‑proBNP) 可作为非心脏手术术后心血管事件发生的生物学指标(证据等级:低,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
N‑末端 B 型利钠肽原 (NT‑proBNP) 可作为非心脏手术术后心血管事件发生的生物学指标(证据等级:低,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3011 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3011.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 中性粒细胞明胶酶相关脂质运载蛋白、尿白细胞介素 18 有可能作为心脏手术后发生急性肾损伤相关的生物标志物(证据等级:低,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
中性粒细胞明胶酶相关脂质运载蛋白、尿白细胞介素 18 有可能作为心脏手术后发生急性肾损伤相关的生物标志物(证据等级:低,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3012 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3012.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 目标导向液体治疗有助于促进腹部大手术患者术后早期进食进饮(证据等级:高,推荐强度:强推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
目标导向液体治疗有助于促进腹部大手术患者术后早期进食进饮(证据等级:高,推荐强度:强推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3013 [catid] => 302 [title] => 中国成人患者围手术期液体治疗临床实践 指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3013.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://guide.medlive.cn/guideline/34040 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2025 [guojia] => 中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 目标导向液体治疗有助于缩短手术后住院时间和 ICU 停留时间(证据等级:高,推荐强度:强推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
目标导向液体治疗有助于缩短手术后住院时间和 ICU 停留时间(证据等级:高,推荐强度:强推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2025

国家:中华医学会麻醉学分会老年人麻醉与围术期管理学组、国家老年麻醉联盟(NAGA) 、国家老年疾病临床医学

阅读
Array ( [id] => 3014 [catid] => 242 [title] => 中国儿童围手术期液体管理指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3014.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://rs.yiigle.com/cmaid/1667662 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2026 [guojia] => 中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 推荐儿童围手术期液体治疗选择复方电解质注射液(证据等级:中,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
推荐儿童围手术期液体治疗选择复方电解质注射液(证据等级:中,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2026

国家:中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202

阅读
Array ( [id] => 3015 [catid] => 242 [title] => 中国儿童围手术期液体管理指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3015.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://rs.yiigle.com/cmaid/1667662 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2026 [guojia] => 中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 推荐儿童围手术期液体治疗选择碳酸氢钠林格注射液(证据等级:低,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
推荐儿童围手术期液体治疗选择碳酸氢钠林格注射液(证据等级:低,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2026

国家:中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202

阅读
Array ( [id] => 3016 [catid] => 242 [title] => 中国儿童围手术期液体管理指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3016.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://rs.yiigle.com/cmaid/1667662 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2026 [guojia] => 中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 推荐儿童围手术期液体治疗选择醋酸钠林格注射液(证据等级:低,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
推荐儿童围手术期液体治疗选择醋酸钠林格注射液(证据等级:低,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2026

国家:中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202

阅读
Array ( [id] => 3017 [catid] => 242 [title] => 中国儿童围手术期液体管理指南(2025版) [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => /show/3017.html [link_id] => 0 [tableid] => 0 [inputip] => 106.86.177.165 [inputtime] => 2026-04-14 11:42:18 [updatetime] => 2026-04-14 11:42:18 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://rs.yiigle.com/cmaid/1667662 [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2026 [guojia] => 中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202 [pdf] => [tjyjyw] => [lyyw] => [laiyuan] => 无复方电解质注射液、碳酸氢钠林格注射液、醋酸钠林格注射液时,及乳酸钠林格液禁忌证时可应用乳酸钠林格注射液(证据等级:低,推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1776138138 [_updatetime] => 1776138138 [_nrjc] => [_nrsh] => )
推荐意见
无复方电解质注射液、碳酸氢钠林格注射液、醋酸钠林格注射液时,及乳酸钠林格液禁忌证时可应用乳酸钠林格注射液(证据等级:低,推荐强度:弱推荐)

证据评价方法:GRADE

指南质量等级:B

年份:2026

国家:中华医学会麻醉学分会小儿麻醉学组、中华医学会麻醉学分会青年学组《中国儿童围手术期液体管理指南(202

阅读